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Possible role of toxoplasmosis in patients with
first-episode schizophrenia*
Mehmet TANYÜKSEL1, Özcan UZUN2, Engin ARAZ1, Özgur KORU1, Cahit BABÜR3

Aim: To determine the possible relationship between toxoplasmosis and patients with first-episode schizophrenia (FES).
Materials and methods: Seventy-three subjects with FES (15-54 years old; mean: 23.4 years) and 40 healthy individuals
(20-54 years old; mean: 30.3 years) were enrolled in the study. Most of the FES patients (90.4%) and the control
individuals (95.0%) were male. Specific IgG and IgM antibodies to Toxoplasma gondii were investigated by enzymelinked immunosorbent assay (ELISA), and the total amount of antibodies was investigated with the Sabin-Feldman dye
test (SFDT).
Results: Compared to the control individuals, study subjects had significantly more toxoplasmosis-like symptoms and
more cats in the household; they were less likely to live in apartments and more likely to live in ground-floor houses. They
did consume more uncooked meat, unpasteurized goat’s milk, and chicken eggs; had more contact with soil; and were
living less often in urban areas and more often in rural areas. Serum samples from 32 (43.8%) and 25 (34.2%) of 73
patients with FES were seropositive for T. gondii when tested by ELISA IgG and SFDT, respectively. Out of 40 serum
samples from control subjects, 13 (32.5%) and 15 (37.5%) were found positive for T. gondii by ELISA IgG and SFDT,
respectively. In patients with FES, 17 (68%) out of 25 who were SFDT-positive were also positive by ELISA IgG test, while
15 out of 48 (31.3%) SFDT-negative serums were positive by ELISA IgG. In the control group, 11 out of 15 SFDT-positive
serum samples (73.3%) were also positive by ELISA IgG test, while 2 out of 25 SFDT-negative serum samples were positive
by ELISA IgG.
Conclusion: The present study shows that toxoplasmosis might be associated with first-episode schizophrenia. More
studies are needed to prove the association between T. gondii infection and patients suffering from schizophrenia.
Key words: Toxoplasma gondii, toxoplasmosis, schizophrenia, ELISA, Sabin-Feldman dye test

İlk atak şizofreni olgularında toksoplazmozun olası rolü
Amaç: Çalışmanın amacı, ilk atak şizofrenili (FES) hastalar ile toksoplazmozun olası ilişkisini saptamak olmuştur.
Yöntem ve gereç: Çalışmaya 73 FES’li (yaşları 15-54 yaş: ortalama 23,4) ve 40 sağlıklı (yaşları 20-54 yaş: ortalama 30,3)
birey alınmıştır. Çalışma gruplarından FES’li hastaların (% 90,4) ve kontrol grubunu (% 95) çoğunlukla erkekler
oluşturmuştur. Toxoplasma gondii’ye spesifik IgG ve IgM antikorları Enzyme Linked Immunosorbent Assay (ELISA) ve
total antikorlar Sabin-Feldman dye test (SFDT) ile saptanmıştır.
Bulgular: Kontrol grubu ile karşılaştırıldığında, çalışma grubunu oluşturan hasta bireylerin daha fazla toksoplazmoz
benzeri semptomlar ve kedi sahibi olmak yönünden istatiksel olarak anlamlı oldukları bulunmuş ve de onların apartman
tarzından ziyade toprakla aynı seviyede olan evlerde yaşadıkları saptanmıştır. Çalışma grubu daha fazla pişmemiş ya da
çiğ et ile pastörize olmayan keçi sütü ve tavuk yumurtası tüketmekte, daha fazla toprakla temasta bulunmakta ve de
şehirden ziyade daha fazla kırsal kesimde yaşamaktaydılar. Serolojik testlere bakıldığında, 73 FES’li hastanın 32’si (%
43,8) ELISA IgG, 25 (% 34,2)’i SFDT ile seropozitif olarak saptanmıştır. Kontrol grubunda, 13’ü (% 32,5) ELISA IgG, 15’i
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(% 37,5) SFDT ile pozitif bulunmuştur. FES’li hastaların analizinde, pozitif 25 SFDT örneğin 17’si (% 68) ELISA IgG ile
de pozitif bulunurken 48 SFDT negatif serumun 15’i (% 31,3) ELISA IgG ile seropozitif bulunmuştur. Kontrol grubunda,
pozitif 15 SFDT örneğin 11’i (% 73,3) ELISA IgG ile de pozitif bulunurken 2 negatif serum ELISA IgG ile seropozitif
bulunmuştur.
Sonuç: Çalışma, toksoplazmozun ilk atak şizofreni ile birliktelik gösterebileceğini ortaya koymaktadır. Şizofreniden
yakınan hastalar ile T. gondii enfeksiyonu birlikteliği hakkında daha fazla çalışmalar yapılmasına gereksinim vardır.
Anahtar sözcükler: Toksoplazmoz, şizofreni, Toxoplasma gondii, ELISA, Sabin-Feldman dye test

Introduction
Schizophrenia is a serious neuropsychiatric disease
of uncertain etiology. Epidemiological and
neuropathological studies have indicated that some
cases of schizophrenia may be associated with
environmental factors, such as exposure to infectious
agents. However, specific infectious agents associated
with the development of schizophrenia have not been
identified (1). In humans, acute infection with
Toxoplasma gondii can produce psychotic symptoms
similar to those displayed by persons with
schizophrenia (2). Consequently, T. gondii may be a
candidate infectious agent related to schizophrenia.
Toxoplasmosis is caused by Toxoplasma gondii, a
human pathogen of cosmopolitan distribution. The
infection is usually prevented by the host immune
response, which is predominately a cellular one;
however, once established, it usually persists
throughout the entire life of the host (3). The
molecular mechanisms of cell invasion by T. gondii
and those leading to cyst formation are largely
unknown, but the preferential location of cysts in the
central nervous system might be related to its specific
immunological status (4). It was found that the
tachyzoite stage of T. gondii can infect both astrocytes
and neurons. However, higher percentages of
astrocytes are infected than neurons, and astrocytes
support more replication of T. gondii than the latter. In
addition, there is evidence that cysts formed in
astrocytes may be distinct from neuronal cysts (5), by
forming tissue cysts that contain numerous “resting”
bradyzoites. Cysts may occur in all tissues, but are
most common in muscle and neural tissue, including
the brain (6).
In the diagnosis of T. gondii infections, the
presence of IgG, IgA, and IgM immunoglobulins does
not always allow a reliable identification of the exact
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stage of the infection. The lack of clear, specific
clinical signs related to toxoplasmosis makes it
difficult to determine the exact time of infection (7).
In Turkey, about 1 out of 3 people become infected
with T. gondii at some point in their lives, and in parts
of continental Europe, up to 80% of the adult
population is infected. This zoonotic disease is
considered one of the major health problems among
parasitic infections. The particular neurotropism of
T. gondii and its association with congenital brain
dysfunction makes it possible to consider a
relationship between exposure to this organism and
the progression of psychiatric diseases (8). Individuals
with schizophrenia may act in ways that increase the
probability of becoming infected with T. gondii either
prior to or after the start of the disorder (8).
The aim of the study was to determine a possible
relationship between toxoplasmosis and first-episode
schizophrenia.
Materials and methods
Study populations
The study was carried out at the schizophrenia
outpatient unit of the Department of Psychiatry,
Gülhane Military Medical Academy, School of
Medicine, Ankara, Turkey. The original study group
comprised 85 subjects. All subjects who were
considered for the present study had been admitted
to the schizophrenia outpatient unit consecutively
between 2002 and 2006. Twelve of the 85 subjects
were excluded from the study because we could not
obtain clear information about their history of
exposure to infectious agents. In the final sample of
73 subjects, the mean age of the subjects was 23.4 ±
5.9 years (range = 15-54 years). Subjects with a past
history of or a concomitant neurological or medical
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illness, or persistent or severe substance abuse, were
excluded. As the control group, 40 healthy individuals
were enrolled in the study. The mean age of the
control group was 30.3 ± 8.8 years (range = 20-54
years). The mean age of the control group was
significantly higher than that of the study group (t =
5.02; P < 0.001). The study and control groups
consisted mainly of males (90.4% and 95.0%,
respectively) (Table 1).
A questionnaire form, prepared by the authors,
was used for the assessment of the subjects’ basic
sociodemographic variables. An additional
questionnaire was used for the assessment of the
subjects’ detailed history of exposure to infectious
agents. All subjects were asked about their history of
toxoplasmosis-like diseases; the presence of cats in the
household and the degree of closeness with these
animals; house type; consumption of uncooked or raw
meat, unpasteurized goat’s milk, and chicken eggs;
contact with soil; residence type (urban or rural); and
blood transfusion and organ transplant history.
Whenever possible, the patient’s history was
corroborated by medical records and family members.
Schizophrenia was diagnosed using the Diagnostic
and Statistical Manual of Mental Disorders (DSM-IV)
criteria (9). In addition, the diagnosis of first-episode
schizophrenia in each participating patient was
confirmed by an experienced psychiatrist (Ö.U.) by
means of the Structured Clinical Interview for DSMIV (SCID) (10).
Ethical aspects
This study was approved by the Ethical Review
Committee of Gülhane Military Medical Academy
(GMMA), Turkey. Informed consent was obtained
from all subjects.
Serological tests
Specific IgG and IgM antibodies to T. gondii were
detected by ELISA IgG and IgM tests (RADIM, Italy)
according to the manufacturer’s recommendations.
Toxoplasma-specific IgG avidity test
IgG avidity was determined with the Toxoplasma
IgG avidity test kit (RADIM, Italy). Values of less than
20% indicated low avidity, values between 20% and
30% were considered to have equivocal avidity, and
values higher than 30% were considered to have high
avidity.

Sabin-Feldman Dye Test (SFDT)
The SFDT measures the total amount of
antibodies in serum that are capable of complementmediated killing of Toxoplasma tachyzoites. Serum
was diluted across a microtiter plate and the end point
was defined as the dilution at which 50% of the
tachyzoites were dead. The SFDT was considered
positive when the titer was above 1/16.
Statistical analysis
All statistical analyses were performed using SPSS
10.0 statistical software (SPSS Inc., Chicago, USA).
Descriptive statistics were shown in either mean ±
standard deviation notation or as frequency tables.
Relations among the categorical variables were
investigated by chi-square test. P-values less than or
equal to 0.05 were considered statistically significant.
Results
Seven out of 73 FES patients (9.6%) presented a
history of toxoplasmosis-like symptoms (fever,
myalgia, dizziness, headache, and lympadenopathy),
while none had chorioretinitis or visceral disease.
Compared to the control individuals, study subjects
had significantly more toxoplasmosis-like symptoms
and more cats in their household; they were living less
often in apartments and more often in ground-floor
houses. They did consume more uncooked meat,
goat’s milk, and chicken eggs; had more contact with
soil; and were living less often in urban areas and
more often in rural areas (Table 1).
Serum samples from 32 (43.8%) and 25 (34.2%) of
73 patients with FES were seropositive for T. gondii
when tested by ELISA IgG and SFDT, respectively.
Only one subject had low IgG avidity (Table 2). Out of
40 serum samples from the control subjects, 13
(32.5%) and 15 (37.5%) were found positive for T.
gondii by ELISA IgG and SFDT, respectively. All of
these subjects had high IgG avidity. All patients and
control subjects were found negative by ELISA IgM.
In patients with FES, 17 (68%) out of 25 who were
SFDT-positive were also found positive by ELISA IgG,
while 15 out of 48 (31.3%) SFDT-negative serums
were positive by ELISA IgG (Table 3). In the control
group, 11 out of 15 SFDT-positive serum samples
(73.3%) were also positive by ELISA IgG, while 2 out
401
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Table 1. Socio-demographic characteristics of subjects.
Study subjects

First-episode
schizophrenia (n = 73)

Age (years)
Sex (male/female)
History of toxoplasma-like disease
Having cat(s) in the household
House type

Control group (n = 40)

Statistics

23.4±5.86

30.3±8.76

P < 0.001

65/8 (90%/10%)

38/2 (95%/5%)

2
χ = 0.742, P = 0.488

7 (9.6%)

0 (0%)

χ2 = 4.08, P = 0.05

15 (28%)

1 (2.5%)

χ2 = 7.62, P = 0.006

a

a

a

χ2 = 17.15, P < 0.001

Apartment

35 (47.9%)

35 (87.5%)

Ground-floor house without backyard

7 (10%)

1 (2.5%)

Ground-floor house with backyard

29 (41%)

4 (10%)

25 (35%)

3 (7.5%)

χ2 = 10.7, P = 0.001

15 (28%)

0 (0%)

χ2 = 8.76, P = 0.002

40 (56.2%)

1 (2.5%)

χ2 = 31.86, P < 0.001

1 (1%)

0 (0%)

Consumption of uncooked or raw meat

a

Consumption of unpasteurized goat’s
milk and chicken eggs
Contact with soil

a

a

Received a blood transfusion or organ transplant
Residence type of community

a

-

a

-

Urban

52 (73%)

40 (100%)

Rural city

19 (27%)

0 (0%)

a

No information was available from 4 patients or their guardians.

Table 2. ELISA and SFDT results in subjects with first-episode schizophrenia and healthy individuals.

ELISA IgM

ELISA IgG

ELISA IgG
Avidity
a

Sabin-Feldman
Dye Test

First-episode
schizophrenia
(n = 73)

Positive
Negative
Total

73
73

32
41
73

1
72b
73

25
48
73

Control group
(n = 40)

Positive
Negative
Total

40
40

13
27
40

0
b
40
40

15
25
40

a

Low avidity, bHigh avidity

of 25 SFDT-negative serum samples were positive by
ELISA IgG (Table 3). Only one FES patient showed a
low avidity by ELISA IgG. In the study group, 6 out of
25 SFDT-seropositive subjects had a titer of 1/16, 15
had a titer of 1/64, and 4 had a titer of 1/256. In the
control group, 6 out of 15 SFDT-seropositive subjects
had a titer of 1/16 and 9 had a titer of 1/64.
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Six patients with schizophrenia were tested again 6
months after the onset of symptoms for IgM and IgG
by ELISA as well as by SFDT. None was positive for
IgM, while one patient sero-converted from positive
to negative regarding IgG. All patients retained high
IgG avidity and 2 who were found positive by SFDT
became negative later.
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Sabin-Feldman
Dye Test

ELISA IgG

ELISA IgM

ELISA IgG
Avidity

+

-

+

-

+

-

Positive (n = 25)
Negative (n = 48)

17
15

8
33

1
-

24
48

1
-

24
48

Total

32

41

1

72

1

72

ELISA IgG
Sabin-Feldman
Dye Test

Control group (n = 40)

First-episode schizophrenia
(n = 73)

Table 3. Comparison of the SFDT with ELISA in subjects with first-episode schizophrenia and healthy individuals.

ELISA IgM

ELISA IgG
Avidity

Positive (n = 15)
Negative (n = 25)

+
11
2

4
23

+
-

15
25

+
-

15
25

Total

13

27

-

40

-

40

Discussion
In our study, no significant differences were found
between FES patients and control individuals
regarding seropositivity to T. gondii. This might be
related to the fact that few seropositive individuals
show clinical symptoms and to the high prevalence of
toxoplasmosis in healthy individuals. This is in
contradiction with other studies that have shown that
seropositivity to T. gondii infection is significantly
higher in schizophrenic patients compared to healthy
matched controls (11). Cetinkaya et al. (12) have
found that the seropositivity rate of T. gondii IgG
antibodies in patients with schizophrenia (66%)
indicates that chronic Toxoplasma infection in these
patients is significantly greater than among patients
with depressive disorder (24%) or healthy volunteers
(22%). Sonmez Tamer et al. (13) detected 40% IgG
and 5% IgM seropositivity among schizophrenic
patients and found that IgG T. gondii antibodies were
significantly higher in schizophrenia patients
compared with controls. Mortensen et al. (14)
reported that T. gondii IgG levels corresponding to the
upper quartile among control subjects were
significantly associated with a risk for schizophrenia
and that there was no significant association between
any marker of infection and other schizophrenia-like
disorders or affective disorders. However, they had no

indication that schizophrenia incidence is closely
linked to endemic variations in T. gondii infections or
any other risk factor. Hinze-Selch et al. (15) suggested
that T. gondii infection, predominantly in individuals
with schizophrenia, is a significant environmental
factor in the interaction between psychiatric
vulnerability, genetic background, immunomodulation,
and the neurotransmitter structures.
In the present study, although significant
differences were not found between the seropositivity
of FES patients and controls, FES patients had
significantly more toxoplasmosis-like symptoms;
came into contact with cats more often; did consume
more uncooked meat, unpasteurized goat’s milk, and
chicken eggs; had more contact with soil; and were
living less often in urban areas and more often in rural
areas. In Ireland, a higher rate of T. gondii-infected
individuals was observed in rural areas (16,17).
Torrey et al. (8), in their meta-analysis of 11
studies, showed that the combined odds ratio was 1.60
(95% confidence interval, 0.98 to 2.69), with the
predicted greater variability among the studies. They
also found that individuals with schizophrenia have
an increased prevalence of antibodies to T. gondii and
suggested that this, as well as genetic and
environmental factors, could be associated with a
large number of cases of schizophrenia.
403

Toxoplasmosis and schizophrenia

Schizophrenia, like multiple sclerosis and
Parkinson's disease, is a chronic disease of the central
nervous system; as with other similar diseases,
infectious agents should be considered as possible
etiologic agents, especially in persons who also have
an increased genetic susceptibility (18).
Our results implied that toxoplasmosis might be,
in fact, a very serious but neglected public health
problem. More studies are needed to show that there

is an association between T. gondii infection and
patients suffering from schizophrenia.
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